Ballard v. Takeda Pharmaceuticals America, Inc.

IN THE SUPREME COURT OF THE STATE OF DELAWARE
ELISHA BALLARD, §
§ No. 361, 2017
Plaintiff Below, §
Appellant, §
§ Court Below: The Superior Court
v. § of the State of Delaware
§
TAKEDA PHARMACEUTICALS § C.A. No. N16C-10-177 JRJ
AMERICA, INC., TAKEDA §
PHARMACEUTICALS U.S.A., §
INC., f/k/a TAKEDA §
PHARMACEUTICALS NORTH §
AMERICA, INC., TAKEDA §
PHARMACEUTICAL COMPANY §
LIMITED, and ELI LILLY AND §
COMPANY, §
§
Defendants Below, §
Appellees. §
Submitted: April 18, 2018
Decided: April 23, 2018
Before STRINE, Chief Justice; SEITZ, and TRAYNOR, Justices.
ORDER
This 23rd day of April 2018, it appears to the Court that the judgment of the
Superior Court should be affirmed on the basis of its opinion dated August 7, 2017.1
1
Ballard v. Takeda Pharm. Am., Inc., 2017 WL 3396488 (Del. Super. Ct. Aug. 7, 2017).
NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior
Court is hereby AFFIRMED.
BY THE COURT:
/s/ Leo E. Strine, Jr.
Chief Justice
2